Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Lipshultz

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
Circulation|July 31, 2012
Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy RegistrySteven A Webber, Steven E Lipshultz, Lynn A Sleeper, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Journal of the American College of Cardiology|December 28, 2010
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study)Steven E Lipshultz, William T Shearer, Bruce Thompson, et al.
Journal of Cardiac Failure|July 13, 2015
Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy RegistryJohn L Jefferies, James D Wilkinson, Lynn A Sleeper, et al.
Clinical Genitourinary Cancer|March 15, 2018
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk ScoreDarren R Feldman, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, et al.
Future Cardiology|November 5, 2013
Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapiesSteven E Lipshultz, Thomas R Cochran, David A Briston, et al.
Journal of the American College of Cardiology|February 25, 2014
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registryMelanie D Everitt, Lynn A Sleeper, Minmin Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Journal of the American Heart Association|January 12, 2024
Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy RegistryPaul F Kantor, Ling Shi, Steven D Colan, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
Circulation|July 31, 2012
Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy RegistrySteven A Webber, Steven E Lipshultz, Lynn A Sleeper, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Journal of the American College of Cardiology|December 28, 2010
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study)Steven E Lipshultz, William T Shearer, Bruce Thompson, et al.
Journal of Cardiac Failure|July 13, 2015
Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy RegistryJohn L Jefferies, James D Wilkinson, Lynn A Sleeper, et al.
Clinical Genitourinary Cancer|March 15, 2018
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk ScoreDarren R Feldman, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, et al.
Future Cardiology|November 5, 2013
Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapiesSteven E Lipshultz, Thomas R Cochran, David A Briston, et al.
Journal of the American College of Cardiology|February 25, 2014
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registryMelanie D Everitt, Lynn A Sleeper, Minmin Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2011
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL ConsortiumLynda M Vrooman, Donna S Neuberg, Kristen E Stevenson, et al.
Journal of the American Heart Association|January 12, 2024
Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy RegistryPaul F Kantor, Ling Shi, Steven D Colan, et al.
Pageof 29